BioMarin Pharmaceutical | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Acadia Pharmaceuticals USD 765.24M 32.44M 2025-03
Agios Pharmaceuticals USD 1.37B 96.97M 2025-06
Alnylam Pharmaceuticals USD 250.59M 135.16M 2025-06
Amgen USD 6.21B 330M 2025-03
Bayer EUR 32.58B 537M 2025-03
Biogen USD 17.63B 655.3M 2025-06
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
Incyte USD 4.17B 503.34M 2025-06
Insmed USD 1.25B 1.15B 2025-06
Ionis Pharmaceuticals USD 631.72M 156M 2025-06
Moderna USD 9.4B 667M 2025-06
Neurocrine Biosciences USD 2.69B 158.6M 2025-06
PTC Therapeutics USD -206546000 20.79M 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 77.86B 4.86B 2024-12
Sarepta Therapeutics USD 1.36B 214.66M 2025-06
Ultragenyx Pharmaceutical USD 151.29M 7.04M 2025-06
United Therapeutics USD 7.17B 366.4M 2025-06
Vertex Pharmaceuticals USD 16.5B 86.7M 2025-03


BioMarin Pharmaceutical Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.